Emergent Biosolutions Inc (EBS)
NYSE
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current EBS market cap is 395.11M. The company's latest EPS is USD -14.5128 and P/E is -0.52.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 165.1M | 337.9M | 269.7M | 276.6M | 300.4M |
| Operating Income | -148.1M | 13.8M | -548.3M | -73.7M | 39.8M |
| Net Income | -183M | -261.3M | -266.7M | -49.5M | 9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.11B | 1.56B | 1.79B | 1.12B | 1.05B |
| Operating Income | 114.1M | 433.8M | 352.6M | -172.7M | -726.4M |
| Net Income | 54.5M | 305.1M | 230.9M | -223.8M | -760.5M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.95B | 2.18B | 1.89B | 1.82B | 1.8B |
| Total Liabilities | 1.75B | 1.22B | 1.2B | 1.17B | 1.14B |
| Total Equity | 1.2B | 956.3M | 697.2M | 649.3M | 663.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.33B | 2.88B | 2.96B | 3.17B | 1.82B |
| Total Liabilities | 1.24B | 1.44B | 1.34B | 1.78B | 1.17B |
| Total Equity | 1.09B | 1.45B | 1.62B | 1.38B | 649.3M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -184M | -298.4M | -238.4M | -206.3M | -62.6M |
| Investing | -15.1M | 242.6M | 223.7M | 212.3M | -10.8M |
| Financing | -10.5M | -497.4M | -540.4M | -535.7M | 40.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 188M | 536M | 321.1M | -34.1M | -206.3M |
| Investing | -96.9M | -151M | -225M | -381.3M | 212.3M |
| Financing | -35.9M | 69.5M | -141M | 481.2M | -535.7M |
| Market Cap | 395.11M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 0.38 |
| Price to Cash Ratio | 3.54 |
| Price to Book Ratio | 0.61 |
| Dividend Yield | - |
| Shares Outstanding | 52.4M |
| Average Volume (1 week) | 4.32M |
| Average Volume (1 Month) | 2.64M |
| 52 Week Change | 1.89% |
| 52 Week High | 8.2875 |
| 52 Week Low | 1.42 |
| Spread (Intraday) | 0.14 (1.84%) |
| Company Name | Emergent Biosolutions Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.emergentbiosolutions.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
